CEimpact Podcast
Download on the App Store

CEimpact Podcast episodes

  • Switching Generics with Levothyroxine

    Current guidelines do not recommend switching between different levothyroxine products due to concerns of potential changes in TSH levels. However, getting the same levothyroxine product every time may be difficult for patients due to financial or stocking constraints. Join your host, Geoff Wall, and guest, Dr. Jamie Pitlick to discuss a recent study that examined the consequences of switching between levothyroxine products. 

    The GameChanger

    Based on a recent study, switching between different levothyroxine products may not significantly or clinically impact TSH levels in patients. 

    Show Segments

    00:00 – Introduction
    01:12 – Generic Substitution of Generic Levothyroxine Products 
    03:17 – Bioequivalence of Levothyroxine Products 
    15:42 – The GameChanger 
    24:47 – Closing Remarks 

    Host

    Geoff Wall, PharmD., BCPS, FCCP, CGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Guest

    Jamie Pitlick, PharmD, BCPS, PC-ADM
    Associate Professor of Pharmacy Practice, Drake University
    Diabetes/Endocrinology Care, Iowa Diabetes

    References and Resources

    Association Between Generic-to-Generic Levothyroxine Switching and Thyrotropin Levels Among US Adults

    Redeem your CPE or CME credit here!

    • Pharmacist members
    • CME

    Need a membership?

    • Join for CPE Credit 
    • Join for CME Credit

     Continuing Education Information:

    Learning Objectives:

    1. Describe the outcomes of the study evaluating the impact of switching levothyroxine generic manufacturers

    2. Discuss with patients the results of the study and clinical implications

    Dr. Wall is a member of the Janssen Speaker's Bureau.

    0.05 CEU | 0.5 Hrs
    ACPE UAN: 0107-0000-22-144-H01-P
    Initial release date: 04/11/22
    Expiration date: 04/11/2023
    Additional CPE & CME details can be found here!

     

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

    26 min
  • Dual Therapy in Depression

    Approximately 1 in 5 individuals in the United States alone will experience depression during their lifetime. Current guidelines suggest that monotherapy may be used as initial therapy for major depressive disorder, but what evidence exists suggesting that starting dual anti-depressant therapy may have better outcomes? Join your host, Geoff Wall as he discusses a recent meta-analysis regarding dual therapy in depression.  

     

    The GameChanger:  

    For initial therapy or patients who are non-respondent to previous treatment, dual anti-depressant therapy may have a small, but significant impact on treatment outcomes, specifically treatment efficacy.  

     

    Show Segments 

    00:00 – Introductions 

    01:19 – Dual Therapy in Depression 

    11:57 – Which Anti-Depressant Combination? 

    15:27 – The GameChanger 

    18:37 – Closing Remarks  

     

    Host:
    Geoff Wall, PharmD., BCPS, FCCP, CGP 
    Professor of Pharmacy Practice, Drake University 
    Internal Medicine/Critical Care, UnityPoint Health 

     

    References and resources: 

    Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression: A Systematic Review and Meta-analysis 

     

    Redeem your CPE or CME credit here! 

    • Pharmacist members 
    • CME 

    Need a membership? 

    • Join for CPE Credit  
    • Join for CME Credit 

     

    Continuing Education Information: 

    Learning Objectives: 

    1. Describe which two classes of antidepressants had the highest remission rate when used together in this study  
    2. Discuss the pros and cons of this meta-analysis including the studies' heterogeneity 

     

    Dr. Wall is a member of the Janssen Speaker's Bureau. 

    0.05 CEU | 0.5 Hrs
    ACPE UAN: 0107-0000-22-143-H01-P
    Initial release date: 04/4/22
    Expiration date: 04/4/2023

    For more information https://www.ceimpact.com/podcast 

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

    20 min
  • Famotidine and Lockdowns - COVID Solutions?

    The world of COVID-19 is always changing. Join Geoff Wall for a rapid fire of updates regarding famotidine, lockdowns, and ivermectin as evaluated for efficacy in COVID-19.

    The GameChangers
    The use of high-dose famotidine in the treatment of COVID-19 has demonstrated moderate safety, but questionable efficacy. Additionally, a recent meta-analysis examining the efficacy of lockdown on the spread of COVID-19 had several limitations that should be taken into consideration. 

    Show Segments

    00:00 – Introductions
    01:56 – Famotidine in the Treatment of COVID-19
    10:52 – Effects of Lockdown on COVID-19 Mortality 
    18:26 – Ivermectin Treatment of COVID-19 in High-Risk Patients 
    23:45 – Closing Remarks 

    Host
    Geoff Wall, PharmD., BCPS, FCCP, CGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Redeem your CPE or CME credit here!

    • Pharmacist members
    • CME

    Need a membership?

    • Join for CPE Credit
    • Join for CME Credit 

    References and resources:

    1. References and resources:
      1.     Oral Famotidine Versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blind, Data-Intense, Phase 2 Clinical Trial
      2.     A Literature Review and Meta-Analysis of the Effects of Lockdowns on COVID-19 Mortality. Pre-Publication.
      3.     Efficacy of Ivermectin Treatment on Disease Progression Among Adults with Mild to Moderate COVID-19 and Comorbidities

    Continuing Education Information:

    Learning Objectives:

    1. 1. Describe the latest information on masks and other non-pharmacologic interventions to halt the spread of COVID-19
      2. Discuss the recent randomized controlled trial evaluating famotidine use in early COVID-19 positive patients

    Dr. Wall is a member of the Janssen Speaker's Bureau.

    0.05 CEU | 0.5 Hrs
    ACPE UAN: 0107-0000-22-142-H01-P
    Initial release date: 03/28/22
    Expiration date: 03/28/2023

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

    25 min
  • Pharmacy Isn't a Vending Machine

    Are you still using post-it notes, clips, and stickers to facilitate your Pharmacy's workflow? You aren't alone - many of us are using tactile tools to run our pharmacies. Even if you are leveraging technology, can you confidently say you are maximizing it? 

    We've come to the point that maximizing technology isn't a choice; it's necessary to save our profession. This episode digs into what pharmacy practice should look like - centering dispensing on the knowledge the pharmacist provides which both maximizes outcomes and ensures safe medication use. 

    In this episode, Community Pharmacist Joe Williams shares his thoughts on the type of pharmacy practice we need to implement to save our profession.  As much as technology supports practice, it doesn't remove the human element. Learn how putting the pharmacist at the center of dispensing can be done through technology. 

    Segments you don’t want to miss:

    5:30 - Pharmacies aren’t just vending machines

    9:58 - The biggest mistake our profession has made…and what we need to do

    12:25 - Technology – it doesn’t replace a Pharmacist – it allows us to survive

    This episode is sponsored by RxSafe, an innovative technology solution designed to accelerate your pharmacy’s success. Learn more about Rxsafe here. Join  The Pharmacy Network to continue this conversation and check out RxSafe in the Practice Resource section!

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

    27 min
  • Failure to Fail

    Perhaps one of the greatest challenges a preceptor has is that of honestly evaluating poor performance in a way that will help get the student either back on track, or connected to the help and support they need, depending on the specific performance issue or issues they are exhibiting. It sounds cold, but in experiential education it has been said more often than once – that sometimes you just have to fail a student for their own benefit and ultimate success. Those conversations are heartbreaking – for the preceptor, for the school’s staff – and most importantly for the students. Listen in as Dr. Lisa Richter and Dr. Kate Newman discuss the evidence and importance of failure in supporting student development.
     
    Host:
    Kathy Schott, PhD
    CEimpact

    Guests:
    Lisa Richter, PharmD
    Director of Experiential Outreach and Assessment
    Assistant Professor of Practice
    North Dakota State University

    Kate Newman, PharmD
    Director of Experiential Education
    Clinical Associate Professor, Department of Pharmacy Practice
    Southern Illinois University Edwardsville

    Get CE
    Click here to access the course and claim CE for the episode.

    CPE Information 

    At the end of this course, preceptors will be able to: 

    1. Identify barriers to providing accurate assessment of underperforming learners 
    2. Discuss strategies to overcome barriers and support accurate assessment of underperforming learners 

    UAN: 0107-0000-25-019-H99-P
    Release Date: 03/24/2025
    Expiration Date: 03/24/2028

     
    Want more education on this and other precepting topics? Check out our Preceptor Library for a full suite of timely and relevant topics for pharmacy preceptors here! 

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

    20 min
  • Exercise is a GameChanger

    Routine exercise is gamechanging. In this epsiode, Geoff is joined by Keaton Higgins, pharmacy student and certified athletic trainer, to discuss the mortality benefits of regular exercise.

    Host
    Geoff Wall, PharmD., BCPS, FCCP, CGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Guest
    Keaton Higgins, ATC
    P3 University of Iowa

    Redeem your CPE or CME credit here!

    • Pharmacist members
    • CME

    Need a membership?

    • Join for CPE Credit
    • Join for CME Credit 

    References and resources:

    Saint-Maurice PF, Graubard BI, Troiano RP, et al. Estimated Number of Deaths Prevented Through Increased Physical Activity Among US Adults. JAMA Intern Med. Published online January 24, 2022. doi:10.1001/jamainternmed.2021.7755

    Continuing Education Information:

    Learning Objectives:
    1. Describe the association of physical activity and mortality
    2. Discuss the role of exercise in delaying mortality

    Dr. Wall is a member of the Janssen Speaker's Bureau.

    0.05 CEU | 0.5 Hrs
    ACPE UAN: 0107-0000-22-114-H04-P
    Initial release date: 03/21/22
    Expiration date: 03/21/2023

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

    24 min
  • Using Adherence to Expand Care

    Level Up: Is your pharmacy ready for the future and able to handle the present environment?

    Listen in to learn how you can strengthen the brick-and-mortar experience in your pharmacy and remain viable in an increasingly online world.

    In this episode, Dr. Ben McNabb pharmacist and owner at Love Oak Pharmacy discusses the current and future state of community pharmacy.  Oak Love Pharmacy is a local Texas-based Community Pharmacy that provides Point-of-Care testing, Immunizations, Diabetes and Adherence services to the 18,000 members of their county.  Ben shares how you can learn from his best practices such as leveraging technology to expand your services.

    This episode is sponsored by RxSafe, an innovative technology solutions designed to accelerate your pharmacy’s success. Learn more about RxSafe here and check the RxSafe from the Practice Resources section of The Pharmacy Network.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

    18 min
  • New Drugs

    Direct to consumer marketing has been a GameChanger in recent years. As new drugs are approved and marketed, healthcare teams must stay ahead of the news and advertisements in order to educate patients and peers on the risks, benefits, and nuances that impact our patients and our practice. Tune into this special, extended 90-minute episode to catch up on recent medications impacting practice.

     

    Host:

    John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
    Course Content and Developer, CEimpact
    Pharmacist, Ross Bridge Pharmacy
    CEO, Seguridad, Inc.

    Dr. Galdo serves in an advisory role and as a member of a speaker’s bureau for Novo Nordisk.

     

    Guest:

    Joe Strain Pharm.D
    Clinical Faculty
    South Dakota State University College of
    Pharmacy and Allied Health Professions

    Dr. Strain has no relevant financial relationships to disclose.

    References and Resources
    Dr. Strain prepared slides for this episode with all references and citations, click HERE to download.

    Already a member? Redeem your CPE or CME credit here!
    Pharmacist Members
    CME
    Pharmacy Technicians

    Need a membership?
    Join for CPE Credit
    Join for CME Credit

    This episode was made possible by the PharmaCE Expo and the Iowa Pharmacy Association. Register for this year's PharmaCE Expo May 17-18 at the Hilton Des Moines Downtown here! Pharmacists and pharmacy technicians who register receive CPE for this course AND have the opportunity to receive over 14 hours of CE for pharmacists and pharmacy technicians. 


    Learning Objectives – Pharmacists and Prescribers

    Upon successful completion of this knowledge-based CPE activity, participants should be able to: 

    1. Summarize therapeutic indications of medications recently approved by the FDA.
    2. Discuss pharmacological properties of the new medications.
    3. List side effects, warnings, precautions, and significant drug interactions associated with the new medications.
    4. Identify the normal dose and dosage forms of the new medications.
    5. Describe limitations to implementing the new medications into clinical practice.  

    0.15 CEU/1.5 hr

    UAN: 0107-0000-22-117-H01-P

    Learning Objectives – Pharmacy Technicians

    Upon successful completion of this knowledge-based CPE activity, participants should be able to:

    1. Identify new medications recently approved by the FDA.
    2. List the classification for the new medications.
    3. Recall major indications for the new medications.
    4. Locate the usual dose and route of administration information for new medications.
    5. Discuss the cost associated with each of the new medications.

    0.15 CEU/1.5 hr

    UAN: 0107-0000-22-117-H01-T 

    Initial release date: 03/14/2022
    Planned expiration date: 03/14/2023
    Additional CPE and CME details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

    1 hr 41 min
  • tooktake

    Up to 69% of #Hospitalizations are caused by Medication Non-Adherence. Think of the impact pharmacists could make on the healthcare spend and patient outcomes if we could have a significant impact on that!

    Tooktake is a new medication reminder. This episode explores how you can offer a new, simple and inexpensive wellness tool to help your patients. It's a new medication reminder called “tooktake”.

    Find out more about tooktake.

    Guest
    Leeanna Gantt, Founder tooktake

    Links to learn more and order tooktake:

    • Get some samples
    • Order
    • Website for Patients
    • Videos on How to use tooktake

    For more information or access to these tools - check out the Practice Resource section of The Pharmacy Network.

    Read more about Leeanna's story on how she started tooktake in CEimpact's blog.

    The Level Up podcast is where we share tools and resources to help you 'level up' your pharmacy practice. 

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

    18 min

About CEimpact Podcast

From the publisher's feed

The CEimpact Podcast features two shows: 

GameChangers Clinical Updates 

Precept2Practice

GameChangers Clinical Update: 
Hosted by Rachel…

More shows like CEimpact Podcast

Criminal by Vox Media Podcast Network

Criminal

37,571 Listeners

Wait Wait... Don't Tell Me! by NPR

Wait Wait... Don't Tell Me!

38,652 Listeners

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast by Pharmacy Joe

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

258 Listeners

Focus on the Family with Jim Daly by Focus on the Family

Focus on the Family with Jim Daly

4,746 Listeners

Pod Save America by Pod Save America

Pod Save America

87,189 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,336 Listeners

The Daily by The New York Times

The Daily

111,845 Listeners

iForumRx.org by American College of Clinical Pharmacy

iForumRx.org

35 Listeners

Up First from NPR by NPR

Up First from NPR

56,400 Listeners

Scripted Wealth | Money & Meaning for Pharmacists by YFP Wealth

Scripted Wealth | Money & Meaning for Pharmacists

171 Listeners

WHOA That's Good Podcast by Sadie Robertson Huff

WHOA That's Good Podcast

13,223 Listeners

The Rachel Cruze Show by Ramsey Network

The Rachel Cruze Show

3,658 Listeners

Catalyst Pharmacy Podcast by RedSail Technologies

Catalyst Pharmacy Podcast

35 Listeners

Crazy Little Thing Called Marriage by Focus on the Family

Crazy Little Thing Called Marriage

31 Listeners

Clinical Capsules - Actionable Medication Pearls in Minutes by TRC Healthcare | Pharmacist's Letter | Prescriber Insights | Pharmacy Technician's Letter

Clinical Capsules - Actionable Medication Pearls in Minutes

3 Listeners